Covered recipient · General Payments record
ROBERT WILSON
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2018–2021
$369.19
- Reported across 26 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2021 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $115.28 | 9 |
By paying entity
PY2021 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $26.91 | 2 |
| GlaxoSmithKline, LLC. | $26.89 | 2 |
| Teva Pharmaceuticals USA, Inc. | $24.31 | 2 |
| Lilly USA, LLC | $12.99 | 1 |
| EISAI INC. | $12.46 | 1 |
| Esperion Therapeutics, Inc. | $11.72 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2021 (9)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| AbbVie Inc. | $15.00 | 04/15/2021 | Food and Beverage | Undisputed | 01/23/2026 | 796262925 | CMS |
| AbbVie Inc. | $11.91 | 05/19/2021 | Food and Beverage | Undisputed | 01/23/2026 | 796262927 | CMS |
| Eisai Inc. | $12.46 | 03/09/2021 | Food and Beverage | Undisputed | 01/23/2026 | 817851533 | CMS |
| Esperion Therapeutics, Inc. | $11.72 | 05/06/2021 | Food and Beverage | Undisputed | 01/23/2026 | 838438159 | CMS |
| GlaxoSmithKline, LLC. | $13.43 | 02/22/2021 | Food and Beverage | Undisputed | 01/23/2026 | 801568387 | CMS |
| GlaxoSmithKline, LLC. | $13.46 | 06/29/2021 | Food and Beverage | Undisputed | 01/23/2026 | 802560397 | CMS |
| Lilly USA, LLC | $12.99 | 01/26/2021 | Food and Beverage | Undisputed | 01/23/2026 | 818730221 | CMS |
| Teva Pharmaceuticals USA, Inc. | $11.85 | 02/03/2021 | Food and Beverage | Undisputed | 01/23/2026 | 839648335 | CMS |
| Teva Pharmaceuticals USA, Inc. | $12.46 | 02/25/2021 | Food and Beverage | Undisputed | 01/23/2026 | 839648339 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021
- Generated from
- OP_DTL_GNRL_PGYR2021_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.